Do you put weight back on after stopping Mounjaro?

What trial data tell us about weight regain when tirzepatide stops

The clearest evidence comes from SURMOUNT-4, a phase-3 extension study in which adults who had already completed 36 weeks of tirzepatide treatment were then randomised either to continue the medicine or to switch to placebo for a further 52 weeks. Those who continued tirzepatide maintained their weight loss and, on average, lost a further 5–6% of body weight. Those who switched to placebo regained roughly half of what they had originally lost over that same year.

This pattern is not unique to tirzepatide. A similar rebound was documented in the STEP 4 semaglutide trial, published in the New England Journal of Medicine, reinforcing the view that GLP-1 class medicines address an ongoing biological process rather than producing a one-off correction. Stopping the medicine does not undo the lessons your body learned; it does, however, remove the physiological brake on appetite that the drug was providing.

The scale of regain varied between individuals in SURMOUNT-4. Some participants retained more of their loss than others, and the factors associated with better outcomes included higher levels of physical activity and dietary patterns that were sustained after the drug was withdrawn. Worth knowing before you make any decision about your treatment.

Why the body tends to reclaim lost weight after stopping

Tirzepatide acts on two gut-hormone receptors, GIP and GLP-1, suppressing appetite, slowing how quickly the stomach empties, and influencing how the brain registers fullness. The NHS patient information for tirzepatide explains this dual mechanism in accessible terms. Once the medicine is stopped and clears the body, appetite-signalling hormones return towards their pre-treatment levels. For many people, that means hunger returns more strongly than it felt during treatment — sometimes more intensely than expected.

There is also a metabolic dimension. The body's resting energy expenditure can fall as weight is lost, which is a well-documented response to calorie restriction that persists after the restriction ends. This is not a personal failing; it is a physiological adaptation that has been documented in research for decades. Understanding it matters because it explains why maintaining weight lost through any method (medicine, surgery or diet alone) requires ongoing effort or ongoing support.

For context on how tirzepatide works as a treatment and what distinguishes it from other medicines in this class, our overview covers the mechanism in full. If you are thinking about what happens to your weight across the whole arc of treatment and beyond, what to expect in the period after stopping Mounjaro goes into more practical detail.

What you can do to protect the weight you have lost

The clinical guidance is consistent on this point: the best outcomes after stopping tirzepatide belong to people who used the treatment period to build habits rather than to simply eat less. Protein adequacy, regular resistance or strength-based activity, and awareness of portion cues all reduce the steepness of any rebound. None of this is new information, but the appetite-suppressive effect of the medicine creates a window in which many people find these changes genuinely easier to establish.

Planned transitions matter too. A prescriber may suggest tapering the dose gradually rather than stopping abruptly, which gives the body a slower adjustment to the change in appetite signals. Some patients move to a lower maintenance dose rather than stopping entirely; others plan a defined break with a clear plan to restart if weight regain reaches a clinical threshold. These are conversations to have with your prescriber, not decisions to make unilaterally. You can read more about restarting Mounjaro after a break if that is the direction you are considering.

It is also worth understanding what treatment actually costs before planning around it long-term. Our page on Mounjaro pricing in the UK covers what the market looks like and what a legitimate private prescription includes. At nume, pricing is transparent: one figure covers the clinical consultation, the prescription, and next-working-day delivery in plain DPD packaging, no subscription, no automatic renewal, and a prescriber who reads your file before every repeat order.

When stopping Mounjaro is the right call, and how to do it safely

There are situations in which stopping is absolutely the right decision: an unwanted side effect that is not settling, a planned pregnancy (tirzepatide is not recommended in pregnancy), a period of illness, or a surgical procedure for which your anaesthetist needs to know you are on this class of medicine. The NHS England guidance on weight management injections covers these situations clearly, including advice on contraception and surgical planning.

If you are stopping because treatment has stalled or you feel unsupported, that is worth discussing rather than acting on quietly. A prescriber can review whether a dose change, a different medicine, or a structured lifestyle addition would address what is not working. The question of whether you will regain weight after stopping Mounjaro often has a more nuanced answer when you look at it with a clinician rather than alone. Similarly, if you have already stopped and are watching the scales move up, what to do if weight returns after stopping Mounjaro outlines the options available to you, including evidence on restarting.

If you are at the stage of considering whether to begin treatment, our prescribers at nume review every consultation personally, a clinician reads your answers, not a piece of software. Check your eligibility for a free consultation to explore whether Mounjaro is appropriate for you and what a treatment plan might realistically look like.